Immune system changes in those with hypertension when infected with SARS-CoV-2

Area of Science:

• Immunology
• Cardiovascular Medicine
• Infectious Diseases

Background:

• COVID-19 poses a global health crisis, with hypertension increasingly recognized as a significant comorbidity.
• Hypertension is linked to immune system dysregulation, including altered T cell populations, cytokine profiles, and innate immune cells.
• Individuals with hypertension face elevated risks of infection, severe COVID-19 complications, and mortality.

Purpose of the Study:

• To systematically review the intricate relationship between primary hypertension and COVID-19.
• To elucidate the immunological mechanisms underlying the interplay between hypertension and SARS-CoV-2 infection.
• To provide evidence-based treatment guidelines for managing COVID-19 in patients with primary hypertension.

Main Methods:

• Comprehensive literature search of recent studies on hypertension, immune response, and COVID-19.
• Synthesis of data on immunological pathways involving CD4+, CD8+ T cells, IL-17/Treg balance, macrophages, NK cells, neutrophils, B cells, and cytokines.
• Analysis of clinical outcomes and treatment strategies in hypertensive COVID-19 patients.

Main Results:

• Primary hypertension significantly impacts immune responses, potentially exacerbating COVID-19 severity.
• Specific immune cell populations and cytokine imbalances are implicated in the heightened vulnerability of hypertensive individuals.
• COVID-19 infection can influence blood pressure regulation and complicate hypertension management.

Conclusions:

• Understanding the immune-mediated links between hypertension and COVID-19 is crucial for risk stratification.
• Tailored treatment strategies are necessary to optimize care for hypertensive patients with COVID-19.
• Further research is warranted to fully delineate the complex interactions and refine therapeutic approaches.